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Introduction High healthcare costs make illness 
precarious for both patients and their families’ economic 
situation. Despite the recent focus on the interconnection 
between health and financial risk at the systemic level, 
the ethical conflict between concerns for potential health 
benefits and financial risk protection at the household 
level in a low-income setting is less understood.
Methods Using a seven-step ethical analysis, we 
examine a real-life dilemma faced by families and health 
workers at the micro level in ethiopia and analyse the 
acceptability of limiting treatment for an ill newborn 
to protect against financial risk. We assess available 
evidence and ethical issues at stake and discuss the 
dilemma with respect to three priority setting criteria: 
health maximisation, priority to the worse-off and 
financial risk protection.
results Giving priority to health maximisation and 
extra priority to the worse-off suggests, in this particular 
case, that limiting treatment is not acceptable even if 
the total well-being gain from reduced financial risk is 
taken into account. Our conclusion depends on the facts 
of the case and the relative weight assigned to these 
criteria. However, there are problematic aspects with the 
premise of this dilemma. The most affected parties—the 
newborn, family members and health worker—cannot 
make free choices about whether to limit treatment or 
not, and we thereby accept deprivations of people’s 
substantive freedoms.
Conclusion In settings where healthcare is financed 
largely out-of-pocket, families and health workers face 
tragic trade-offs. as countries move towards universal 
health coverage, financial risk protection for high-priority 
services is necessary to promote fairness, improve health 
and reduce poverty.
InTroduCTIon
Worldwide, neonatal mortality is decreasing, but 
still 2.6 million newborns die annually within 
their first month of life.1 Contributing to 8% of 
disability-adjusted life years (DALYs) lost globally 
every year, this largely avoidable burden mainly 
affect babies in low-income and middle-income 
countries.1 Seventy-one per cent of newborn 
deaths, mostly caused by prematurity, intrapartum 
complications and sepsis,1 could be prevented or 
treated with effective interventions.2 From a global 
perspective, one can argue that ill newborns are 
worse-off for different reasons. They have large 
and urgent immediate health needs and will suffer 
from the largest individual lifetime health loss if 
they die prematurely. Among ill newborns, some 
are worse-off than others, as there are inequali-
ties in use of services across socioeconomic groups 
(figure 1), rural/urban location and gender.3 
Limited healthcare budgets challenge current 
initiatives to secure access to healthcare services 
for all neonates. In particular, in low-income coun-
tries, where public spending on health often is low,4 
discussions about healthcare priority setting and 
newborn health become important.
Fairness in priority setting
In general, several criteria have been suggested 
to support the fair allocation of scarce resources. 
While there is disagreement on how to balance 
these, two principles form the basis for much of 
the discussion.5 The greater benefit principle can 
be understood as giving priority to interventions 
with greater health benefits. The worse-off prin-
ciple is concerned with giving priority to those 
who are worse-off initially. These principles are 
often applied with a focus on direct health bene-
fits, but some claim we should consider indirect or 
non-health benefits and burdens as well.6
The high economic burden of healthcare 
expenses makes it relevant to consider financial risk 
protection in priority setting at macro and meso 
levels.3 In health systems that largely depend on 
out-of-pocket (OOP) payments, healthcare costs 
put patients and their families at risk of poor health 
outcomes and impoverishment.3 Globally, 21% of 
total health expenditures are paid OOP, increasing 
up to 50% in low-income countries.7 As a part of 
the United Nations Sustainable Development Goals, 
all 193 member states have committed to achieving 
universal health coverage (UHC), which includes 
protection against financial risk when using health-
care services.8 As countries move towards achieving 
this goal, they will face priority setting dilemmas. 
The WHO framework, Making fair choices on the 
path to universal health coverage, suggests three 
substantive criteria to guide policy-makers in 
defining priority services.3 The health maximisa-
tion criterion gives priority to cost-effective inter-
ventions. The priority to the worse-off criterion 
prioritises interventions that benefit individuals 
or groups that are worse-off.i The financial risk 
i In the WHO framework, the worse-off in terms of health 
is understood as those with the largest individual disease 
burden.3
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protection criterion prefers interventions that protect against 
high OOP expenses. The criteria may all point in one direction, 
or concerns may conflict. If so, the WHO framework suggests 
that concerns should be carefully balanced. Decision-makers 
may disagree on how to evaluate lives saved versus poverty cases 
averted.3 Further, while priority setting discussions often focus 
on trade-offs at the policy and macro level,3 few have analysed 
diverging concerns for financial risk protection and health bene-
fits at the micro level.9
Financial risk protection at the micro level
In previous studies of families’ and healthcare workers’ ethical 
dilemmas in Ethiopia, we found that concerns about finan-
cial risk protection were central in micro-level healthcare 
decision-making. In a setting without UHC, families with ill 
newborns struggled to pay OOP for healthcare; they had to 
borrow and sell their assets. Facing high costs, families and 
health workers made decisions that required balancing the needs 
of ill newborns versus other household needs. Families’ oppor-
tunities to seek care, obtain services and follow medical advice 
depended on their social and economic assets.10 11 Some families 
had no option but to delay care-seeking, which had tragic conse-
quences. One father explained, “Since I didn’t have enough 
money, she died before I took her there (referral hospital).”10 
When living on the margin, the families’ worry did not only 
concern the ill newborn but impacted the whole family. One 
mother was concerned about the future of her other children. 
“I had nothing, and I sold the only sheep I had to get treatment 
for my child. When the sheep is not there, what will I do in the 
future?”10
In an Ethiopian survey, 83% of physicians regularly withheld 
recommended treatment because patients could not afford services. 
They often protected patients against high costs by limiting prescrip-
tion of drugs or diagnostics and compromised by offering subop-
timal care.12 In their daily practice, physicians often had to choose 
between two evils, either poorer health outcomes for the patient or 
harmful economic consequences for the family.9
As these studies describe, families’ and health workers’ decisions 
on care-seeking often involve choices between diverging concerns 
for individual health and family welfare. Whereas priority setting 
trade-offs at macro level fortunately have received academic and 
policy attention,3 we find that there is a need to further scrutinise the 
common dilemma between financial risk and health benefits at micro 
level. By analysing a stylised case (box 1), our aim is to outline ethical 
concerns and normative implications of limiting treatment for an ill 
newborn to protect against financial risk. The micro-level dilemma 
in box 1 is discussed with reference to criteria for priority setting 
proposed in the WHO framework (health maximisation, priority 
to the worse-off, financial risk protection).3 Though this framework 
was developed for priority setting by policy-makers and technical 
advisors, we could not identify any other systematic framework that 
explicitly considers financial risk, which we found to be at the centre 
of families’ and health workers’ everyday dilemmas.9–11
It should be noted that our discussion is grounded in the specific 
case from rural Ethiopia (box 1). We do not aim to provide a 
general conclusion on the inherent trade-off between health and 
welfare, which occurs in different settings and at multiple levels.
MeThods
Drawing on earlier empirical work on micro-level priority setting in 
Ethiopia, we present an anonymised and stylised case in box 1.9–12 
The micro-level dilemma was analysed using a modified version of 
Kymlica’s ethical case analysis as described by Miljeteig et al.13 In a 
seven-step analysis, we assess available evidence, clarify options for 
concerned parties, identify conflicts between interests and ethical 
principles, and suggest acceptable solutions (box 2). The analytic 
tool cannot offer guidance for how to reconcile competing interests 
of stakeholders involved or conclude on how to balance conflicting 
values and ethical principles. However, it is used to structure rele-
vant information and ethical concerns at stake in the dilemma. This 
systematic approach supports a discussion on what matters most, 
the acceptability of the trade-off, and what are potential legitimate 
solutions.
Figure 1 Coverage of newborn healthcare services per 
wealth quintile. Data source: Ethiopia Demographic and 
Health Survey 2016.18
Box 1 An ill newborn in a poor family in rural ethiopia
A mother and father have brought their 2-day-old newborn to a 
health centre in rural Ethiopia. Two days after a difficult 24-hour 
birth at home, the baby has still not taken breast. The health worker 
recognises that the newborn is in respiratory distress and suspects 
neonatal sepsis. From a medical perspective, the condition is severe, 
and the baby should be referred to the hospital, as the health centre 
does not offer intravenous treatment with antibiotics and supportive 
treatment. The father, who is a daily labourer, is in distress about 
the expenses for drugs and the hospital stay. He states, “How can 
we afford? We used everything we had and have no money. If I sell 
our seeds to pay for treatment, how will I get food for her brothers 
and sister? Can they go to school? Now, they will suffer”. The health 
worker is afraid the baby will not be taken to the hospital and may 
die. She asks herself, “Should I try to convince them to go? Will I 
force them into economic disaster? How should I negotiate?”
Box 2 seven-step ethical analysis13
Gather information. If insufficient, ask for more.
Step I: What is the ethical dilemma and alternative actions?
Step II: What do we know about the outcomes of 
alternatives?
Step III: What laws, rules or guidelines regulate the decision?
Step IV: Who are the involved stakeholders?
Step V: What are the stakeholders’ potential burdens and 
benefits?
Step VI: What interests are in conflict?
Step VII: What are the values and principles at stake?
Discuss what is most important in the case; clarify trade-offs and suggest 
acceptable solutions.
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eThICAl AnAlysIs
What is the ethical dilemma and alternative actions?
Is it ethically acceptable to limit treatmentii for the ill 
newborn, in this case to protect the family against financial 
risk? Alternative responses are yes, it is acceptable, or no, it is 
not acceptable.
What do we know about the outcomes of alternatives?
We evaluated evidence on the possible outcomes of both alter-
natives (limiting treatment for the newborn or not) and looked 
at health outcomes, costs and financial burden with and without 
treatment (table 1).
health outcomes
The burden of neonatal sepsis and infections contributes to 
0.1%, and 2.9% of DALYs lost in high-income and low-in-
come countries, respectively. In Ethiopia, neonatal sepsis and 
infections account for 3.1% of DALYs lost and 14 600 deaths 
annually.1
WHO guidelines for neonatal sepsis recommend antibiotic treat-
ment (ampicillin and gentamicin).14 When skilled attendance is 0% 
and 100%, the case fatality rate is predicted to be 30% and 10%, 
respectively.15 In the ethical dilemma analysed, the health worker 
identified the ill newborn in need of inpatient care, and we conser-
vatively assume the case fatality rate without treatment to be more 
than 50%.16 A Delphi consultation indicated that hospital-based 
management, including intravenous antibiotics and supportive 
care, could reduce sepsis-specific and pneumonia-specific mortality 
by 80% and 90%, respectively.15
Average life expectancy at birth in Ethiopia is 65 years.1 Even 
if the newborn survives from sepsis, a systematic review found 
that 49% of septic premature neonates developed long-term 
ii Limiting treatment is understood as not receiving recommended antibi-
otics and supportive treatment at the referral hospital.
sequels.17 Though less is known about subsequent effects of 
sepsis in term babies, it is likely that some encounter physical, 
neurological and cognitive impairment.16 17 Thus, in this case, 
we assume that also if the newborn survives septicaemia, she 
is at increased risk of morbidity, increased health and welfare 
support, and lower life expectancy (<<65 yearsiii).
Being poor relate to poorer health outcomes, lower care-
seeking and relatively higher burden of high healthcare costs.18 
If the family falls into poverty due to high OOP expenses after 
paying for advanced treatment, household members may be 
of risk of worse health in the future. Current choices about 
healthcare-seeking hereby influence the future health (as well 
as welfare, see next paragraph) of the newborn and the family.
Costs
A facility-based study from Ethiopia found that the mean OOP 
cost of admission for severe pneumonia was US$64 per inpa-
tient visit (0–59 months).19 While the relative burden of these 
costs may differ between poor and less well-off families, we—
for simplicity—assume that the cost of treatment is similar 
for newborn sepsis. Bhutta et al estimated that a package 
of interventions to address stillbirth, neonatal and maternal 
deaths could be provided at US$60 per DALY averted.2 Since 
the 2015 gross domestic product (GDP) per capita in Ethiopia 
was US$619,20 treatment of the ill newborn can be considered 
highly cost-effective.
Financial burden
In the case analysed, the father expressed that costs of seeking 
healthcare are too high and was worried about the welfare and 
food supply for the family if he has to sell their seeds.
Health systems that largely depend on OOP payments 
rather than prepayments expose households for great financial 
risk and poor health.3 In Ethiopia, 48% of healthcare costs 
for children are covered OOP payments.21 We assume that 
neonatal sepsis and infections account for 20% of all deaths 
from respiratory infections.1 Extrapolating from Verguet et 
al’s study on the burden of medical impoverishment in Ethi-
opia, we estimate that neonatal pneumonia and sepsis cause 
11 800 poverty cases per year.22
Thirty-four per cent of the Ethiopian population lives on 
less than US$1.90 a day (2011 PPP).20 When we adjust the 
cost of treatment for purchasing power, the OOP expendi-
ture of US$64 equals about US$175 (current international 
purchasing power parities (PPPs)).19 The family in the case 
is likely to live below the poverty line, and we estimate 
the relative impact of treatment to be close to 3 months’ 
spending (US$175/US$1.90=92 days).20 These estimates 
indicate that the consequences for family welfare are severe. 
The financial well-being of the household is likely to influ-
ence the future of the family and the newborn. Yet, the 
monetary value in our estimates may not fully reflect the 
real loss for the family. If they sell their seeds, there will be 
an immediate loss as well as an impact on future sources of 
food and income. This may influence other family members, 
where the newborn and other children may get less food, 
can no longer go to school, or the parents must find addi-
tional sources of income.
iii Data on long-term outcomes of sepsis in term newborns in resource-con-
strained settings are limited.16 17
Table 1 Potential outcomes of alternative actions 
option I: limit 
treatment to provide 
protection against 
financial risk
option II: Provide 
treatment, which 
contributes to financial 
risk
Medical prognosis of 
newborn*
  Case fatality rate 0.50 0.1 
  Life expectancy <1  month <<65  years 
Costs of treatment for 
family
  Cost of treatment ≈0 US$64 (absolute)
US$175 (PPP adjusted)
(Additional costs for 
newborn with sequel)
Financial risk
  Impact on available 
resources† 
≈0 3 months of spending
(Additional impacts of 
spending on newborn with 
sequel)
*Assuming that the newborn with severe neonatal sepsis has low chances 
without treatment. 
†Assuming that the family lives below the poverty line (below US$1.90/day, 2011 
PPP).
PPP, purchasing power parity. 
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What laws, rules or guidelines regulate the decision?
Ethiopia ratified the United Nations Convention on the Rights 
of the Child in 1991. The Convention recognises the right of 
children to have the highest attainable standard of health and the 
obligation of the state to pursue implementation.23
For this analysis, two strategies by the Federal Ministry of 
Health are of particular relevance. The National Strategy for 
Newborn and Child Survival in Ethiopia focuses on goals and 
plans to ensure coverage of high-impact neonatal interventions 
with an emphasis on marginalised populations.24 In the Health 
Sector Transformation Plan V, Ethiopia has committed to move 
towards UHC, where necessary services are to be made acces-
sible for everyone while providing protection against financial 
risk.21 However, there is limited guidance on how to incor-
porate concerns about financial risk in priority setting and 
decision-making.
WHO guidelines and national treatment guidelines on 
neonatal illness and sepsis clearly state that the newborn - in this 
case - should be treated.14
Who are the involved stakeholders?
The most-affected parties are the ill newborn, the parents, other 
children in the family, the healthcare worker, other ill newborns, 
community members, society, policy-makers and international 
stakeholders.
What are the stakeholders’ potential burdens and benefits?
We consider benefits and burdens of affected parties if treatment 
for the ill newborn is withheld to protect against financial risk 
(table 2).
The largest benefits will be for other family members. By 
restricting treatment, the family avoids devastating costs for their 
already-vulnerable economic situation. The costs of treatment 
may push them into the vicious circle of poverty and ill health. 
The most severe burden will be on the ill newborn, who will lose 
out on better survival chances when not receiving medical treat-
ment. Health workers might experience moral and professional 
stress if the newborn is not treated.
If it is perceived as acceptable to give priority to household needs 
over newborn health in the community, this might delay seeking 
care for other ill newborns.11 Although policy-makers and interna-
tional stakeholders will not be directly affected by one additional 
newborn death or one additional poverty case, general trends in 
newborn mortality and OOP expenses are relevant for their work.
What interests are in conflict?
The direct interests of the newborn, the parents and other 
children of the family are in conflict. Without treatment, the 
newborn’s chances of survival are lower, and the newborn may 
die. It is in the economic interest of the parents and siblings to 
not sell their assets, in this case, their seeds, to avoid financial 
ruin. At the same time, the loss of a newborn is an emotional 
burden and a future productivity loss for the family.
Indirectly, the interests at stake and conflict between the 
newborn and the family’s interests affect the health worker. From 
a professional view, the health worker’s obligations concern the 
patient. However, in handling the dilemma, the physician is likely 
to be challenged by concerns for family welfare.9
What are the values and principles at stake?
There are several values and principles at stake in this dilemma, 
such as respecting patient autonomy, the healthcare worker’s 
duty to care and the principles to do good (beneficence) and do 
no harm (non-maleficence).25 Following a non-consequentialist 
approach, the healthcare worker’s duty to provide a life-saving 
treatment may very well override all other concerns for the well-
being of other family members. Yet, the purpose of our anal-
ysis was to discuss the ethical acceptability of prioritising health 
versus welfare, which we discuss with regards to the criteria in 
the WHO framework. In our discussion of justice and fairness, 
we pay particular attention to health maximisation, priority to 
the worse-off and financial risk protection.3
Maximising health
The newborn, if treated, can expect to live up. Though she has 
an increased risk of long-term complications,16 17 the most likely 
outcome is survival without sequels. Limiting highly cost-effective 
treatment would not maximise health.2 The newborn will most 
likely die.
Table 2 Benefits and burdens of limiting treatment to protect against financial risk
benefits burden
The ill newborn No direct benefit The chance of survival decreases, and the newborn is likely to die
The parents Avoid selling their harvest/seeds
Avoid risk of catastrophic health expenditures
More resources for food and other necessities
Emotional burden of losing a baby
Future productive loss of losing a child
Immediate funeral costs, etc.
Long-term lost income if the child lived
The other children More resources for other children: improved nourishment, opportunity to go 
to school, improved health
Emotional and productive burden of losing a sibling
The health worker Protecting the family against high costs and financial risk Moral distress of not providing treatment to the ill newborn
Professional stress when not following medical guidelines
Other ill newborns Indirect: More physcial room and public resources for other ill newborns in 
the hospital
Indirect: Shape perceptions and practices of (not) seeking treatment for ill 
newborns
Community members Friends and neighbours have to lend money to family with ill newborn Loss of a new child
Fear that high costs of treatment might delay care-seeking for others
Society Avoid further poverty Loss of one citizen
Policy-makers Less families experiencing high OOP payments
Success in financial risk protection outcomes
Higher newborn mortality rate
Lack of success in newborn mortality
International 
stakeholders
Less poverty cases due to high OOP payments
Success in financial risk protection outcomes
Higher newborn mortality rate
Lack of success of newborn health programmes or funding
OOP, out of pocket.
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Priority to the worse-off
The WHO framework identifies the worse-off in terms of health 
as those with the largest individual disease burden.3 26 iv The ill 
newborn is worse-off in terms of potential lifetime health loss, and 
benefits to the newborn should therefore have extra weight. Even if 
we include non-health outcomes, no other person in the family is as 
badly off as the ill newborn, although the total well-being loss to the 
family due to the financial burden may be larger. Thus, the weight 
assigned to the worst-off, in this case the newborn, will affect the 
aggregated sum of benefits and burdens under the two alternatives.
Protecting against financial risk
At the micro level, concerns for financial risk protection for all 
family members may favour limiting treatment for the newborn. 
Some may argue that improved well-being outcomes for the 
parents and older children, taken together, are more important 
than the improved health outcome for the newborn. We grant 
that the unweighted sum of well-being for the family, in this 
case, may be greater than the burden for the newborn if left to 
die. Yet, the well-being gain for each member of the family is, in 
this case, substantially smaller than the burden imposed on the 
newborn. The key question is whether these smaller benefits for 
many outweigh the larger loss for the one newborn.
Altogether, when we assess the total burdens and benefits for 
all family members compared with the well-being loss and gain 
for the newborn, the latter outweighs the former when additional 
weight is assigned to the health benefits for the worse-off. This 
is a judgement made by the authors—we attach a large weight 
to the substantial benefit of survival for the newborn—and we 
acknowledge that others, including the mother and father in this 
case, may reach a different conclusion.
dIsCussIon
health benefits or financial risk protection?
The stakes are high in the micro-level dilemmas families and health 
workers face in settings without UHC. The empirically derived case 
is constructed, but we have reason to believe that patients, next 
of kins and healthcare professionals face similar choices in settings 
where healthcare is largely financed OOP. The ethical dilemma 
concerns what to do when family members or health workers 
cannot both improve health and protect against financial risk. For 
the father and mother: should they sell their seeds to pay for treat-
ment, or not? For the health worker: should she advise the parents 
to seek care at the hospital, or not? At worst, their choices can cause 
newborn death, economic disaster or both.
Central in this dilemma is the value judgement on whether to take 
well-being beyond health outcomes into account or not.6 27 Should 
we consider only direct health benefits or include non-health and 
indirect benefits? Brock has argued that "different activities have 
different distinct purposes".27 The purposes of these activities, such 
as healthcare services to improve health, should determine their 
"proper sphere", and goods and resources should be distributed 
based on the activities they produce.27 While the argument to sepa-
rate allocation of health and non-health benefits may hold in an 
ideal world, the pragmatic reality seen in the real-life dilemmas illus-
trated in our case shows how spheres are not separated at house-
hold level. As long as patients pay OOP for healthcare services, 
families’ decisions are constrained by one budget, and both health 
and non-health concerns are taken into account in intra-household 
iv The literature on badness of death discusses other ways to assess when 
it is worst to die.26
decisions. Persad and du Toit argue that relying on separate spheres 
through "tunnel-vision approaches" in health policies is a mistake.6
We agree and accept that well-being beyond health is rele-
vant, and that health maximisation, priority to the worse-off and 
financial risk protection are ethically relevant criteria for priority 
setting. However, it is not clear what to do when these concerns 
conflict.3 Depending on which outcome one values most, and 
for whom, one may conclude that it is either acceptable or 
unacceptable to limit treatment. Though limiting treatment can 
secure 3 months of daily expenses and thus secure a total well-
being gain for the whole household, the baby has a high chance 
if dying and is clearly worse-off than the others (table 1). In our 
all-things-considered judgement, where gains to the worse-off 
are given additional weight, we incline towards the option that 
limiting treatment is not acceptable.
Does this mean that we accept the real-life implications of this 
position? It may suggest that it is wrong for the family to with-
hold treatment from the newborn, and that the health profes-
sional should attempt to persuade them to borrow money or 
sell their seeds to afford treatment. Although we, as authors, 
make this judgement, we accept that the family may come to a 
different conclusion based on their balancing of expected gains 
and burdens. Health professionals can help clarify this choice 
and provide relevant arguments, but in this particular context 
the family will and should make the final decision.
unacceptable real-life dilemmas
Our case highlights a real-life dilemma between promoting health 
benefits and reducing financial risk that plays out in healthcare 
systems worldwide.28 However, from a normative perspective, 
there are problematic consequences of accepting this situation 
and treating it merely as a dilemma where an ethically accept-
able solution can be found. As a society, we should not accept 
that the worst-off newborn dies from a disease that could have 
been easily avoided with cost-effective interventions or that the 
family falls into financial ruin. The unfair choices imposed on 
the family and health worker is caused by priorities and choices 
made at health system level.
In their reflections on distributive justice, it is relevant to consider 
how people’s preferences, beliefs and choices are shaped by under-
lying conditions.29 30 Following Sen’s capabilities approach, being 
poor and ill—as seen in the case analysed—can be understood as 
deprivations of freedoms.29 Both as means and ends, poverty and 
ill health may restrict people’s capabilities to ‘live the kind of life 
they have reason to value’.29Conceptualised as adaptive preferences, 
Sen and Nussbaum discuss how individuals adjust their preferences 
based on the choices that are available to them.31 32 In the dilemma 
analysed, the most-affected parties—the newborn, family members 
and health worker—cannot make free choices about whether to 
limit treatment or not. There is reason to believe that they would 
value treating the newborn without ending in financial ruin, but 
without money, this is not a real option.10 We argue that the 
situation in which the ethical dilemma plays out is unacceptable 
and unfair. Worldwide, healthcare is often financed by patients 
and their families, and opportunities to survive and enjoy lives 
without poverty often depend on economic factors. Our discus-
sion demonstrates that the resource-constraints settings in which 
these dilemmas occur compromise people’s substantive freedoms 
and could have been avoided by pooling resources for high-priority 
health services.
Micro-dilemmas and macro-decisions
Policy-level questions on UHC typically centre on which services 
to include, to whom they should be provided and how to protect 
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against financial hardship.3 Organisation and implementation of 
health and welfare systems, closely connected to macro-decisions, 
influence micro-level practices and opportunities. Dilemmas faced 
by families and health workers (box 1) are shaped by policy choices 
at higher levels of the system. In Ethiopia, life expectancy increased 
by 9 years between 2005 and 2015,1 and in 2013, total health 
spending was 4.7% of GDP.7 An essential healthcare package is 
being implemented, and advanced medical treatments such as renal 
transplants and cancer care are about to be implemented in selected 
hospitals.21 Although these new services seem promising, expanding 
access to low-priority and medium-priority services when larger 
parts of the population cannot access or afford high-priority 
services is problematic.3 33 From a fairness perspective, reducing 
OOP payments for essential services, such as antibiotic treatment 
for neonatal infections, is more important than ensuring access 
to expensive and less-effective services, such as advanced cancer 
treatment.21 If basic newborn healthcare services were provided at 
no or low cost, the unacceptable ethical dilemma analysed in this 
study would not be present. Trade-offs between health and welfare 
may always be present, but examples such as the case analysed are 
particularly problematic. For cost-effective services for a group that 
is worse-off in terms of health and well-being, lower-level deci-
sion-makers should not be left to choose between health benefits 
and financial risk protection. Progressive realisation of UHC can 
make care-seeking without falling into poverty a reality, which 
may intrinsically and instrumentally enhance people’s capabilities.3 
Ethiopia’s roll-out of community-based and social health insurance 
represents promising steps away from financing models based on 
OOP payments and voluntary mechanisms. Yet, to progressively 
realise UHC here and in countries worldwide, it is urgent to make 
high-priority services affordable.
Methodological concerns
A better understanding of real-life dilemmas is relevant for 
health policies and for normative discussions to illuminate what 
justice—and injustice—means. As far as we know, this is one of the 
first attempts to explicitly analyse a micro-level ethical dilemma 
where concerns for health benefits and financial risk protection 
diverge. Some important methodological considerations should 
be noted. We chose the WHO framework for our analysis, which 
included financial risk, a criterion that has received little atten-
tion in the medical ethics literature. However, it did not take 
bedside rationing considerations, such as health professionals’ 
duty to care, into account.9 12 While this may have left out rele-
vant principles or values, it was a deliberate choice on our part 
as we aimed to focus on financial risk. Further discussion of the 
health–welfare trade-off, whether these concerns are incommen-
surable, and the role of professional duties, are of great interest 
but beyond the aim of this study.
The strength of evidence on outcomes can be questioned. In 
the analysis, we simply assumed that the baby suffered from 
neonatal sepsis and could be saved. In real life, health outcomes 
may depend on additional factors such as quality of treatment, 
appropriate care and the aetiology of illness.16 17 This may also 
hold for our assumptions on financial risk, where data are even 
more limited. To address these challenges and research gaps, 
further empirical studies on financial burden and indirect costs 
and benefits,19 22 and normative discussion on how to weigh 
health and non-health concerns are needed.6
Studies show that healthcare financing in low-income coun-
tries is particularly dependent on OOP payments.4 7 Though 
our analysis deliberately focused on one case from Ethiopia, it is 
likely that similar tragic dilemmas are seen in other settings, and 
especially in underfinanced healthcare systems. While essential 
newborn health services are very effective, analysis of other 
services for other less severe diseases may influence the balance 
in the health–welfare trade-off towards a different conclusion. 
Though context always matters, we still believe the ethical issues 
highlighted are relevant for discussions on fairness and financial 
risk protection.
ConCludInG reMArks
By analysing an ethical dilemma in a resource-constrained 
setting, we have seen that non-health factors challenge our 
views about which principles matter in priority setting and how 
conflicting concerns should be balanced. Families’ and health 
workers’ choices about health benefits or protection against 
financial ruin play out at micro level, but are influenced by 
macro-level decisions and priorities. If we neglect the fact that 
non-health factors affect real-life priority setting, in particular 
the health and welfare of the poor, this neglect may perpetuate 
and reinforce inattention to underlying structural issues that 
shape health and development.
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